Published in BMC Genomics on March 03, 2010
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ (2013) 0.94
Comparison of ultra-conserved elements in drosophilids and vertebrates. PLoS One (2013) 0.81
A transcribed ultraconserved noncoding RNA, Uc.173, is a key molecule for the inhibition of lead-induced neuronal apoptosis. Oncotarget (2016) 0.77
Establishment of a protocol for large-scale gene expression analyses of laser capture microdissected bladder tissue. World J Urol (2012) 0.75
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem (2009) 40.90
Ultraconserved elements in the human genome. Science (2004) 17.14
A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature (2006) 5.98
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40
RDML: structured language and reporting guidelines for real-time quantitative PCR data. Nucleic Acids Res (2009) 2.72
High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res (2008) 2.71
Into the heart of darkness: large-scale clustering of human non-coding DNA. Bioinformatics (2004) 2.50
Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications. Clin Chem (2005) 2.10
Linear mRNA amplification from as little as 5 ng total RNA for global gene expression analysis. Biotechniques (2004) 2.04
Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J Immunol Methods (2003) 1.42
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer (2009) 1.29
RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts. BMC Res Notes (2009) 1.20
Influence of stochastics on quantitative PCR in the detection of minimal residual disease. Leukemia (2003) 0.86
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol (2009) 3.07
The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutat Res (2008) 2.13
Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg (2010) 2.08
Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem (2006) 1.94
Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol (2006) 1.79
Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study. PLoS One (2013) 1.55
A bibliometric analysis of scientific production in cancer molecular epidemiology. Carcinogenesis (2007) 1.54
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol (2003) 1.47
Prognostic impact of gene expression-based classification for neuroblastoma. J Clin Oncol (2010) 1.43
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. Cancer Res (2009) 1.41
MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma. Pediatr Blood Cancer (2010) 1.40
Buccal micronucleus cytome assay. Nat Protoc (2009) 1.36
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci (2013) 1.32
γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res (2013) 1.30
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer (2009) 1.29
Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res (2004) 1.24
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis. Mutat Res (2005) 1.22
Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer (2007) 1.21
Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p. Hum Hered (2007) 1.19
Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect (2005) 1.16
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis (2012) 1.14
The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis (2011) 1.10
Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer (2007) 1.08
Clinical relevance of action observation in upper-limb stroke rehabilitation: a possible role in recovery of functional dexterity. A randomized clinical trial. Neurorehabil Neural Repair (2012) 1.08
Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer (2012) 1.07
Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory. Cancer (2008) 1.06
Micronuclei frequency in children exposed to environmental mutagens: a review. Mutat Res (2003) 1.05
Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins. PLoS One (2012) 1.03
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients. Clin Cancer Res (2008) 1.03
Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. Environ Health Perspect (2008) 1.03
Retrospective study of childhood ganglioneuroma. J Clin Oncol (2008) 1.02
Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer. Free Radic Biol Med (2006) 1.02
The HUMN and HUMNxL international collaboration projects on human micronucleus assays in lymphocytes and buccal cells--past, present and future. Mutagenesis (2011) 1.01
Weak linkage at 4p16 to predisposition for human neuroblastoma. Oncogene (2002) 1.00
Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat Res (2007) 1.00
An overview of the genetic structure within the Italian population from genome-wide data. PLoS One (2012) 1.00
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet (2007) 0.99
Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma. Int J Cancer (2012) 0.99
Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis (2011) 0.99
Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene (2005) 0.98
Pemetrexed for the treatment of non-small cell lung cancer. Expert Opin Pharmacother (2013) 0.96
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine. Curr Drug Targets (2015) 0.95
Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors. Mol Cancer Res (2011) 0.94
hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis (2007) 0.93
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. Int J Biol Markers (2009) 0.93
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial. J Headache Pain (2012) 0.93
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int J Cancer (2007) 0.93
Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues. Mutat Res (2005) 0.93
A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res (2011) 0.92
Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients. Int J Cancer (2010) 0.92
Human population studies with the exfoliated buccal micronucleus assay: statistical and epidemiological issues. Mutat Res (2009) 0.92
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res (2008) 0.91
Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms. Carcinogenesis (2004) 0.91
Estimating the lowest detectable dose of ionizing radiation by the cytokinesis-block micronucleus assay. Radiat Res (2013) 0.90
The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. Cancer Epidemiol Biomarkers Prev (2008) 0.90
Baseline micronuclei frequency in children: estimates from meta- and pooled analyses. Environ Health Perspect (2005) 0.90
Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma. Am J Med Genet A (2003) 0.90
Linkage analysis in families with recurrent neuroblastoma. Ann N Y Acad Sci (2002) 0.90
Characterisation and validation of insertions and deletions in 173 patient exomes. PLoS One (2012) 0.89
High genomic instability predicts survival in metastatic high-risk neuroblastoma. Neoplasia (2012) 0.89
Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors. Pediatr Blood Cancer (2011) 0.89
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998. Diabetes Care (2003) 0.88
Multiple mechanisms of transmitter release evoked by "pathologically" elevated extracellular [K+]: involvement of transporter reversal and mitochondrial calcium. J Neurochem (2002) 0.88
An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells. Int J Cancer (2007) 0.87
Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma. Cancer Res (2013) 0.86
"DNA-Dressed NAnopore" for complementary sequence detection. Biosens Bioelectron (2011) 0.86
Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Mol Cancer Ther (2008) 0.86
Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies. Mutat Res (2012) 0.86
Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry. Eur J Cancer (2009) 0.85
Methodological issues in pooled analysis of biomarker studies. Mutat Res (2002) 0.85
State of the art survey of the buccal micronucleus assay--a first stage in the HUMN(XL) project initiative. Mutagenesis (2009) 0.85
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform. Neoplasia (2012) 0.85
Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat Res (2007) 0.85
DNA methylation in neuroblastic tumors. Cancer Lett (2005) 0.85
Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell. Prostate (2013) 0.84